Form 8-K - Current report:
SEC Accession No. 0001181431-13-039583
Filing Date
2013-07-11
Accepted
2013-07-11 17:00:53
Documents
2
Period of Report
2013-07-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rrd385738.htm 8-K 15535
2 PRESS RELEASE, DATED JULY 11, 2013, TITLED "DYNAVAX APPOINTS ROBERT JANSSEN, M.D rrd385738_39713.htm EX-99 4196
  Complete submission text file 0001181431-13-039583.txt   21027
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 13964361
SIC: 2834 Pharmaceutical Preparations